TEMECULA, Calif., Feb. 26, 2014 /PRNewswire/ -- Hop-on, Inc
(OTC:HPNN.PK) announced today its subsidiary, Re-Medical, Inc., is
setting up distribution of cannabis transdermal patches in legal
jurisdictions, with the first being Colorado.
Re-Medical's mission is to provide solutions for patients
desiring to use cannabis as a nutraceutical alternative to
traditional or prescription medications.
Re-Medical is a Hop-on company focused on alternative ways to
deliver vitamins, supplements and other healthful products such as
cannabis, utilizing transdermal patches. The company has developed
and isolated the benefits of cannabis and other vital plant
extracts for best patient care. There are an estimated 80+
cannabinoids found in cannabis, each providing distinctive
neuropathic effects. The company is currently applying for patents
regarding the delivery of cannabis via transdermal patches.
Re-Medical patches offer cost effective, accurate and clean
delivery of these unique compounds.
Re-Medical's transdermal patch has a variety of choices for both
high THC and high CBD cannabis users to medicate in a precisely
dosed, discreet, clean delivery method. Re-Medical offers the high
THC and high CBD transdermal patches in 10mg and 20mg doses.
Hop-on, Inc. (HPNN.PK) is a global ODM and OEM
manufacturer of electronics, based in the United States. Over
the past 20 years, Hop-on has successfully secured essential
patents for mobile communications and computing technologies, and
is respected for developing the world's first disposable cell
phone. Hop-on's focus on smartphones and innovative mobile device
applications is bringing cost friendly solutions to today's
demanding world market. Hop-on is also diversified in delivering
cannabis remedies. For more information, please visit
www.re-medical.com
For more information: email
Contact person: Peter Michaels
949-756-9008
Read more news from Hop-on, Inc.
Forward-Looking Statements
Certain statements in this news release may contain forward-looking
information within the meaning of Rule 175 under the Securities Act
of 1933, and are subject to Rule 3B-6 under the Securities Exchange
Act of 1934, and are subject to the safe harbor created by those
rules. All statements, other than statements of fact, included in
this release, including, without limitation, statements regarding
potential future plans and objectives of the company, are
forward-looking statements that involve risks and uncertainties.
There can be no assurance that such statements will prove to be
accurate and other results and further events could differ
materially from those anticipated in such statements. Future events
and actual results could differ materially from those set forth in,
contemplated by, or underlying the forward-looking statements.
SOURCE Hop-on, Inc.